Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
by from Morbidity and Mortality Weekly Report (MMWR) on (#5V7VS)
This report describes updated recommendations from the ACIP to the use of Janssen mRNA COVID-19 vaccines.